Skip to main content
SpringerLink
Log in

Lamotrigine is effective in patients with newly diagnosed epilepsy

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gabapentin and lamotrigine: worthwhile in refractory partial epilepsy. Drug Ther Perspect 1993 Nov 22; 2(10): 1–4

    Google Scholar 

  2. Fitton A, Goa KL. Lamotrigine: an update of its pharmacology and therapeutic use in epilepsy. Drugs 1995 Oct; 50(4): 691–713

    Article  PubMed  CAS  Google Scholar 

  3. Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995 Feb 25; 345: 476–9

    Article  PubMed  CAS  Google Scholar 

  4. Yuen AWC et al. Lamotrigine vs carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy [abstract]. Epilepsia 1994; 35 Suppl. 8: 31

    Google Scholar 

  5. Steiner TJ, Silveira C, Yuen AWC, et al. Comparison of lamotrigine (Lamictal) and phenytoin monotherapy in newly diagnosed epilepsy [abstract]. Epilepsia 1994; 35 Suppl. 7: 61

    Google Scholar 

  6. Lamotrigine licensed for monotherapy. Pharm J 1995 Feb 11; 254: 183

    Google Scholar 

  7. Higgins G. Choosing between anticonvulsant drugs [meeting report]. Inpharma 1995 Oct 21; (1009): 13–4

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lamotrigine is effective in patients with newly diagnosed epilepsy. Drugs Ther. Perspect 7, 6–7 (1996). https://doi.org/10.2165/00042310-199607010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607010-00002

Keywords

Search

Navigation